NMRA
Neumora Therapeutics, Inc. · Healthcare
Arch Venture Partners Xii, LLC bought $700K of Neumora Therapeutics, Inc.
10% owner
Bought$700,464
$11.97Price
58,504Shares
+2%Stake
What NMRA did for a copier
- $1,000 copied at Thu, Sep 28 open, $11.82
- $897
- S&P 500, same days
- +2.0%
Measured over 30 trading days, to the Nov 9 close.
Arch Venture Partners Xii, LLC's record
7 other buys with 3 months of prices since 2023: on average +2.4% against the S&P 500, and 4 of 7 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Sep 26. Filed Wed, Sep 27, 8:18 PM ET, after the close. Returns use the Sep 28 open and the Nov 9 close. Not investment advice.